• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Testing for sexually transmitted infections is infrequent among high school students in the United States

byAlexa FineandAlex Gipsman, MD
April 11, 2022
in Chronic Disease, Infectious Disease, Pediatrics, Public Health
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. In a 2019 national survey of 2501 high school students across the United States, only 20.4% of those who were sexually active in the past 3 months were tested for sexually transmitted infections in the past year.

2. Those more likely to have been tested included females, older females, and those who endorsed specific sexual behaviors.

Evidence Rating Level: 3 (Average)

Study Rundown: Sexually transmitted infections (STIs) are common in adolescents and young adults and can lead to long-term complications, including chronic infection and infertility. Annual STI testing, specifically for chlamydial and gonococcal infections, is currently recommended for sexually active adolescents and young adults. This study reported the prevalence of STI testing in roughly 2,500 sexually active high school students from a national sample of students in the United States, and described associations of testing with behavioral and demographic data.. Overall, 20.4% of students were tested for STIs in the past year. Females (26%) were more likely than males (14%) to be tested. Prevalence of testing for males did not differ depending on demographics, however for females older age was associated with higher prevalence of STI testing. Certain sexual behaviors were associated with higher prevalence of testing in males and females, including no condom use at last sexual encounter for both sexes. Prevalence of STI testing for individuals who may have been tested in the past 12 months, but who were not sexually active in the past 3 months, was not investigated. This study indicates STI testing rates are suboptimal in sexually active high school students and screening implementation should be a priority for health care providers, especially for young men, who may be the least likely to seek STI testing.

Click to read the study in PEDIATRICS

Relevant Reading: Reaching youth with sexually transmitted disease testing: Building on successes, challenges, and lessons learned from local get yourself tested campaigns

In-Depth [survey]: This study included data from the 2019 National Youth Risk Behavior Survey, which included a survey of public and private high school students across the United States. Respondents were asked if they were tested for STIs (other than HIV) in the past 12 months. Behavioral questions included sexual intercourse at <13 years of age, ≥4 lifetime sexual partners, ≥2 sexual partners in the past 3 months, alcohol or drug use before last sexual intercourse, and no condom use during last sexual intercourse. Demographic information included age, sex, race/ethnicity, sexual identity, and sex of lifetime sexual contacts. In total, 2501 students who were sexually active in the past 3 months, who answered the initial STI question, were included. Approximately 20% of sexually active students were tested for STIs, with a higher prevalence in females. In males, all sexual behavior indicators except for no condom use at last sexual encounter were associated with increased testing. In females, no condom use at last sexual encounter was the only behavior associated with increased STI testing, after adjusting for demographic data.

RELATED REPORTS

Barriers to medication access for opioid use disorder in adolescents and young adults

mRNA Covid-19 vaccine remained safe and efficacious through 6 months

#VisualAbstract: Only one quarter of benzodiazepine prescriptions in youth are for approved indication

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: adolescent medicinechlamydiagonorrheasexually transmitted infection (STI)
Previous Post

Exposure to hydraulic fracturing sites is associated with some adverse birth outcomes

Next Post

Adjuvant chemotherapy associated with an improved overall survival for patients with locally advanced gastric cancer

RelatedReports

Quick Take: The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): a pragmatic, double-blind, placebo-controlled randomized trial
Chronic Disease

Barriers to medication access for opioid use disorder in adolescents and young adults

April 4, 2022
Novel coronavirus identified from patients with pneumonia in Wuhan, China
Chronic Disease

mRNA Covid-19 vaccine remained safe and efficacious through 6 months

January 26, 2022
#VisualAbstract: Only one quarter of benzodiazepine prescriptions in youth are for approved indication
StudyGraphics

#VisualAbstract: Only one quarter of benzodiazepine prescriptions in youth are for approved indication

December 29, 2021
Quick Take: The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): a pragmatic, double-blind, placebo-controlled randomized trial
Chronic Disease

Only one quarter of benzodiazepine prescriptions in youth are for approved indication

December 24, 2021
Next Post
Quick Take: Combined Surgery and Extensive Intraoperative Peritoneal Lavage vs Surgery Alone for Treatment of Locally Advanced Gastric Cancer: The SEIPLUS Randomized Clinical Tria

Adjuvant chemotherapy associated with an improved overall survival for patients with locally advanced gastric cancer

2 Minute Medicine Rewind October 21, 2019

Engaging in COVID-19 content with peers and on social media may negatively impact mental health

#VisualAbstract: Solid organ transplant recipients are at an increased risk of developing non-melanoma skin cancers

#VisualAbstract: Solid organ transplant recipients are at an increased risk of developing non-melanoma skin cancers

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

Get 2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • #VisualAbstract: Bimekizumab shows a favourable 2-year safety profile in patients with moderate to severe plaque psoriasis
  • Medical cannabis provides little improvement to sleep in chronic pain patients
  • Alzheimer disease in individuals with Down syndrome has similar variability in age of onset and mortality rate as autosomal dominant forms
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.